Alternatives to FORE Biotherapeutics

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.